XICLOFEN Trademark

Trademark Overview


On Monday, July 29, 2024, a trademark application was filed for XICLOFEN with the United States Patent and Trademark Office. The USPTO has given the XICLOFEN trademark a serial number of 98671403. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Thursday, March 5, 2026. This trademark is owned by Strand Health Group LLC. The XICLOFEN trademark is filed in the Pharmaceutical Products category with the following description:

Analgesic preparations
xiclofen

General Information


Serial Number98671403
Word MarkXICLOFEN
Filing DateMonday, July 29, 2024
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateThursday, March 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements


Goods and ServicesAnalgesic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 29, 2024
Primary Code005
First Use Anywhere DateWednesday, July 2, 2025
First Use In Commerce DateWednesday, July 2, 2025

Trademark Owner History


Party NameStrand Health Group LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89102
US

Party NameStrand Health Group LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89102
US

Trademark Events


Event DateEvent Description
Monday, July 29, 2024NEW APPLICATION ENTERED
Monday, July 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 5, 2025ASSIGNED TO EXAMINER
Wednesday, February 5, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 29, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 31, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, January 28, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 28, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 28, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 28, 2026TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, February 4, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 31, 2025USE AMENDMENT FILED
Thursday, February 5, 2026STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 5, 2026SU - NON-FINAL ACTION - WRITTEN
Thursday, March 5, 2026NON-FINAL ACTION E-MAILED
Thursday, March 5, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords


xiclofen preparations analgesic